Showing results (91-100 of 104) with videos related to
Sort By:
Pageof 11
Gastroenterology|December 1, 1996
Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantationM Berenguer, N A Terrault, M Piatak, et al.Kidney International|September 1, 1994
Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: a U.S. National Collaborative StudyB J Pereira, T L Wright, C H Schmid, et al.Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 1, 1995
Low incidence of intraspousal transmission of hepatitis C virus after liver transplantationT M McCashland, T L Wright, J P Donovan, et al.Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 29, 1998
Hepatitis after liver transplantation: the role of the known and unknown virusesM G Pessoa, N A Terrault, L D Ferrell, et al.Hepatology (Baltimore, Md.)|July 1, 1992
Intracranial pressure monitoring and liver transplantation for fulminant hepatic failureS D Lidofsky, N M Bass, M C Prager, et al.The American Journal of Gastroenterology|November 30, 2000
A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotypeM W Fried, M Shiffman, R K Sterling, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 11, 2006
Natural history of patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantationC-K Hui, E Lau, A Monto, et al.The New England Journal of Medicine|December 7, 2000
Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosisE J Heathcote, M L Shiffman, W G Cooksley, et al.Antimicrobial Agents and Chemotherapy|May 23, 2002
Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infectionR G Gish, N W Y Leung, T L Wright, et al.Hepatology (Baltimore, Md.)|May 1, 1997
Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantationM G Pessoa, N A Terrault, L D Ferrell, et al.Pageof 11